In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells
Thomas Cuny(Hôpital de la Conception), Anne Barlier(Inserm)
Cited by 10
Related Papers
<sup>18</sup>F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?
|Journal of Nuclear Medicine|2009|126
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
|Journal of neurosurgery|2016|62
Comparison of [<sup>111</sup>In]pentetreotide‐SPECT and [<sup>18</sup>F]FDOPA‐PET in the localization of extra‐adrenal paragangliomas: the case for a patient‐tailored use of nuclear imaging modalities
|Clinical Endocrinology|2010|42
First Report of Harlequin Syndrome as the Presenting Feature of Carney Triad: A Diagnostic and Imaging Challenge
|Journal of Clinical Oncology|2012|8
Targeting Dopamine Receptors Subtype 2 (D2DR) in Pheochromocytomas: Head-to-Head Comparison Between In Vitro and In Vivo Findings
|The Journal of Clinical Endocrinology & Metabolism|2013|5